The Paris Private Equity team advised the healthcare growth equity firm EW Healthcare Partners on the minority investment in Boiron Développement in order to partially finance the take private of Boiron SA, which will be completed through Boiron Développement.
Boiron is an independent, family-run pharmaceutical laboratory specializing in the production of very high quality homeopathic medicine.
With over $4 billion raised since inception, EW Healthcare Partners is one of the oldest and most respected private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe.
The Goodwin team was led by Maxence Bloch and included Rodolphe Amaudric du Chaffaut and Carla Candela on corporate aspects, Arnaud Fromion on financing aspects, and Charles-Henri de Gouvion Saint Cyr and Gauthier Pinabiaux on tax aspects.